Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas W Morrell

Showing results (81-90 of 278) with videos related to

Pageof 28
Sort By:
Human Molecular Genetics|March 7, 2008
Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertensionM Talat Nasim, Amar Ghouri, Bhakti Patel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 29, 2011
Late outgrowth endothelial progenitor cells engineered for improved survival and maintenance of function in transplant-related injuryJing Zhao, Eleanor M Bolton, Mark L Ormiston, et al.
Pulmonary Circulation|October 3, 2022
A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolismMargaret R MacLean, Divya Pandya, Emilia M Swietlik, et al.
Chest|December 24, 2005
Does BMPR2 mutation disrupt pulmonary vasculogenesis?Trina K Jeffery, Paul D Upton, X Yang, et al.
Human Molecular Genetics|October 30, 2003
Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertensionRajiv D Machado, Nung Rudarakanchana, Carl Atkinson, et al.
Canadian Journal of Physiology and Pharmacology|December 18, 2018
Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension <sup>1</sup>Qiuwang Zhang, Liana Zucco, Mark Toshner, et al.
Human Molecular Genetics|May 15, 2013
The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutationsBenjamin J Dunmore, Kylie M Drake, Paul D Upton, et al.
American Journal of Respiratory Cell and Molecular Biology|September 29, 2017
Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary HypertensionAfshan Dean, Teja Gregorc, Craig K Docherty, et al.
Pulmonary Circulation|June 10, 2017
The Pulmonary Vascular Research Institute celebrates its first decadeJason X-J Yuan, Nicholas W Morrell, Kurt R Stenmark, et al.
Circulation|April 10, 2002
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptorCarl Atkinson, Susan Stewart, Paul D Upton, et al.
Pageof 28

Showing results (81-90 of 278) with videos related to

Sort By:
Pageof 28
Human Molecular Genetics|March 7, 2008
Stoichiometric imbalance in the receptor complex contributes to dysfunctional BMPR-II mediated signalling in pulmonary arterial hypertensionM Talat Nasim, Amar Ghouri, Bhakti Patel, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 29, 2011
Late outgrowth endothelial progenitor cells engineered for improved survival and maintenance of function in transplant-related injuryJing Zhao, Eleanor M Bolton, Mark L Ormiston, et al.
Pulmonary Circulation|October 3, 2022
A pilot study to examine association of BMI with functional class and 6 min walk distance in idiopathic and heritable PAH: Possible association with estrogen metabolismMargaret R MacLean, Divya Pandya, Emilia M Swietlik, et al.
Chest|December 24, 2005
Does BMPR2 mutation disrupt pulmonary vasculogenesis?Trina K Jeffery, Paul D Upton, X Yang, et al.
Human Molecular Genetics|October 30, 2003
Functional interaction between BMPR-II and Tctex-1, a light chain of Dynein, is isoform-specific and disrupted by mutations underlying primary pulmonary hypertensionRajiv D Machado, Nung Rudarakanchana, Carl Atkinson, et al.
Canadian Journal of Physiology and Pharmacology|December 18, 2018
Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension <sup>1</sup>Qiuwang Zhang, Liana Zucco, Mark Toshner, et al.
Human Molecular Genetics|May 15, 2013
The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutationsBenjamin J Dunmore, Kylie M Drake, Paul D Upton, et al.
American Journal of Respiratory Cell and Molecular Biology|September 29, 2017
Role of the Aryl Hydrocarbon Receptor in Sugen 5416-induced Experimental Pulmonary HypertensionAfshan Dean, Teja Gregorc, Craig K Docherty, et al.
Pulmonary Circulation|June 10, 2017
The Pulmonary Vascular Research Institute celebrates its first decadeJason X-J Yuan, Nicholas W Morrell, Kurt R Stenmark, et al.
Circulation|April 10, 2002
Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptorCarl Atkinson, Susan Stewart, Paul D Upton, et al.
Pageof 28